Clinical Trial Update: CANF-Comb-II PET-MR in Atherosclerosis Multisite

View source ↗

Summary

The CANF-Comb-II PET-MR in Atherosclerosis multisite trial is currently recruiting participants for carotid atherosclerosis and related conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asymptomatic Carotid Artery Stenosis
• Carotid Artery Atheroma
• Carotid Atherosclerosis

Drugs mentioned

• CANF-Comb-II

Snippet

Sponsor: Washington University School of Medicine | Conditions: Carotid Atherosclerosis, Asymptomatic Carotid Artery Stenosis | Status: RECRUITING